Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cognition Therapeutics, Inc. (CGTX) had Operating Cash Flow per Share of $-0.53 for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-8.14M |
|
-- |
|
-- |
|
$15.19M |
|
$-15.19M |
|
$7.05M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-8.14M |
|
$-15.19M |
|
$-15.12M |
|
30.03M |
|
30.03M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$34.22M |
|
$0.28M |
|
$0.94M |
|
$35.16M |
|
$10.17M |
|
-- |
|
$0.52M |
|
$10.69M |
|
$24.47M |
|
$24.47M |
|
$24.47M |
|
32.16M |
|
| Cash Flow Statement Financials | |
$-16.02M |
|
$-0.15M |
|
$4.52M |
|
$41.56M |
|
$29.92M |
|
$-11.64M |
|
$4.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.26% |
|
-33.26% |
|
-23.15% |
|
-33.26% |
|
$0.76 |
|
$-0.54 |
|
|
Operating Cash Flow per Share |
$-0.53 |